The Role of Progranulin in Cholangiocarcinoma Growth
颗粒体蛋白前体在胆管癌生长中的作用
基本信息
- 批准号:7870645
- 负责人:
- 金额:$ 7.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:BiliaryBiliary Tract CancerBindingBoxingCCAAT-Enhancer-Binding ProteinsCell LineCell ProliferationCellsCholangiocarcinomaDataDevelopmentDiagnosisEarly DiagnosisEpithelial CellsEtiologyEventGene ExpressionGenesGoalsGrowthGrowth FactorHealthHepaticIL6 Signaling PathwayInterleukin-6Life ExpectancyMalignant - descriptorMalignant NeoplasmsMitogen-Activated Protein Kinase 3MolecularNeoplastic Cell TransformationPGRN genePathway interactionsPlayProductionProgranulinPropertyRPS6KA geneRecombinantsRelative (related person)ResearchResistanceRoleSignal TransductionSymptomsTestingTissuesTranscriptional RegulationTumor Cell InvasionWorkbasebile ductbiliary tractcell growthchemotherapycholangiocytedesigneffective therapyforkhead proteinneoplastic cellnoveloutcome forecastpromoterpublic health relevanceresearch studyribosomal protein S6 kinase 2therapeutic developmenttranscription factortreatment strategytumor growth
项目摘要
DESCRIPTION (provided by applicant): Neoplastic transformation of intra- and extra-hepatic biliary epithelial cells (cholangiocytes), gives rise to cholangiocarcinoma, a devastating cancer that has a very poor prognosis. Early diagnosis is difficult as symptoms usually arise as a result of bile duct blockage and relative resistance to current chemotherapies makes for a short life expectancy after diagnosis. Therefore, research into the control of cholangiocarcinoma cell growth is imperative to design more effective treatment strategies. We have obtained novel preliminary data indicating that there is an over production of the growth factor progranulin in cholangiocarcinoma cells and tissue and thus, suggest that this factor may play a role in the progression of cholangiocarcinoma. The overall objective of this proposal is to determine the molecular mechanisms by which progranulin is upregulated and to determine the consequences of increased progranulin production on cell growth. Our proposed work will focus on two specific aims that have been designed to test the following hypotheses: 1) Progranulin is upregulated in cholangiocarcinoma as a result of aberrant IL-6 expression via an ERK1/2/RSK/C/EBP(-dependent pathway. 2) Progranulin has growth promoting properties on cholangiocarcinoma via the IP3/Ca2?dependent inhibition of FOXO1 transcriptional activity. The elucidation of the mechanism by which progranulin production is increased in cholangiocarcinoma and the consequences of the increased progranulin levels on cholangiocarcinoma cell growth will be important in understanding the etiology of cholangiocarcinoma and may play a paramount role in the development of therapeutic strategies for the treatment of cholangiocarcinoma.
PUBLIC HEALTH RELEVANCE: Cholangiocarcinoma is a devastating cancer of the biliary tract that has poor prognosis and limited treatment options. The health relatedness of this application is that dissecting the mechanisms that may be responsible for the malignant transformation of cholangiocytes (cells that line the biliary tree) into cholangiocarcinoma can ultimately be expected to provide understanding of the causes of cholangiocarcinoma and increase opportunities for the development of novel treatment regimes for the treatment of this deadly cancer.
描述(由申请人提供):肿瘤内和肝外胆道上皮细胞(胆管细胞)的肿瘤转化会引起胆管癌,这是一种毁灭性的癌症,预后较差。早期诊断很困难,因为症状通常是由于胆管阻塞而引起的,并且对当前化学疗法的相对耐药性会在诊断后短暂预期寿命。因此,对胆管癌细胞生长的控制的研究对于设计更有效的治疗策略至关重要。我们已经获得了新的初步数据,表明胆管癌细胞和组织中生长因子易生肽的过度产生,因此表明该因子可能在胆管癌的进展中起作用。该提案的总体目的是确定易生蛋白上调的分子机制,并确定促进蛋白增加对细胞生长的后果。我们提出的工作将集中在旨在测试以下假设的两个特定目标上:1)由于异常IL-6表达通过ERK1/2/RSK/C/C/EBP表达的胆管癌中,胆管蛋白蛋白会上调。 FOXO1转录活动。阐明胆管癌中促进素蛋白产生的机制以及在胆管癌细胞生长中增加的胆管蛋白水平增加对理解胆管癌的病因的影响至关重要,并可能在治疗胆管瘤治疗的治疗策略的发展中起着至关重要的作用。
公共卫生相关性:胆管癌是胆道的毁灭性癌症,预后较差,治疗方案有限。该应用的健康相关性是,剖析可能导致胆管细胞(将胆道树扎在胆管癌中)恶性转化的机制最终可以预期,可以期望对胆管癌瘤的原因提供理解,并增加治疗方案的这种治疗方法的机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sharon DeMorrow其他文献
Sharon DeMorrow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sharon DeMorrow', 18)}}的其他基金
The role of hypothalamic neuropeptides on biliary function during cholestasis
下丘脑神经肽对胆汁淤积期间胆道功能的作用
- 批准号:
8819803 - 财政年份:2014
- 资助金额:
$ 7.15万 - 项目类别:
The role of hypothalamic neuropeptides on biliary function during cholestasis
下丘脑神经肽对胆汁淤积期间胆道功能的作用
- 批准号:
9275431 - 财政年份:2014
- 资助金额:
$ 7.15万 - 项目类别:
The Role of Progranulin in Cholangiocarcinoma Growth
颗粒体蛋白前体在胆管癌生长中的作用
- 批准号:
8073604 - 财政年份:2010
- 资助金额:
$ 7.15万 - 项目类别:
Dysregulated Hypothalamic-pituitary-adrenal Axis During Biliary Hyperplasia
胆道增生期间下丘脑-垂体-肾上腺轴失调
- 批准号:
8464068 - 财政年份:2010
- 资助金额:
$ 7.15万 - 项目类别:
Dysregulated Hypothalamic-pituitary-adrenal Axis During Biliary Hyperplasia
胆道增生期间下丘脑-垂体-肾上腺轴失调
- 批准号:
8277426 - 财政年份:2010
- 资助金额:
$ 7.15万 - 项目类别:
Dysregulation of hypothalamic neuropeptides is associated with biliary hyperplasia
下丘脑神经肽失调与胆道增生有关
- 批准号:
9750757 - 财政年份:2010
- 资助金额:
$ 7.15万 - 项目类别:
Dysregulated Hypothalamic-pituitary-adrenal Axis During Biliary Hyperplasia
胆道增生期间下丘脑-垂体-肾上腺轴失调
- 批准号:
7983687 - 财政年份:2010
- 资助金额:
$ 7.15万 - 项目类别:
Dysregulated Hypothalamic-pituitary-adrenal Axis During Biliary Hyperplasia
胆道增生期间下丘脑-垂体-肾上腺轴失调
- 批准号:
8661757 - 财政年份:2010
- 资助金额:
$ 7.15万 - 项目类别:
Dysregulated Hypothalamic-pituitary-adrenal Axis During Biliary Hyperplasia
胆道增生期间下丘脑-垂体-肾上腺轴失调
- 批准号:
8090393 - 财政年份:2010
- 资助金额:
$ 7.15万 - 项目类别:
Endocannabinoid Regulation of Cholangiocarcinoma Cell Growth
内源性大麻素对胆管癌细胞生长的调节
- 批准号:
7879813 - 财政年份:2009
- 资助金额:
$ 7.15万 - 项目类别:
相似国自然基金
ARID1A基因变异与胆道癌循环肿瘤细胞表型、上皮间质转化的关系
- 批准号:82173213
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
ARID1A基因变异与胆道癌循环肿瘤细胞表型、上皮间质转化的关系
- 批准号:
- 批准年份:2021
- 资助金额:54.7 万元
- 项目类别:面上项目
Kras突变协同Pten低表达在肝内大胆管周围腺体内胆道干细胞恶化转化中的作用及分子机制
- 批准号:81560460
- 批准年份:2015
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
桥粒芯糖蛋白-2调控EMT在胆道癌侵袭转移中的作用机制研究
- 批准号:81560392
- 批准年份:2015
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
Notch信号通路在ALDH1+/Musashi+胆囊癌干细胞中功能研究
- 批准号:81472738
- 批准年份:2014
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
Investigating the molecular mechanisms of growth in GNAS mutant pancreatic cancer.
研究 GNAS 突变型胰腺癌生长的分子机制。
- 批准号:
10666643 - 财政年份:2022
- 资助金额:
$ 7.15万 - 项目类别:
HER2-mediated delivery of cytotoxic agents in solid tumors
实体瘤中 HER2 介导的细胞毒药物递送
- 批准号:
10381517 - 财政年份:2021
- 资助金额:
$ 7.15万 - 项目类别:
HER2-mediated delivery of cytotoxic agents in solid tumors
实体瘤中 HER2 介导的细胞毒药物递送
- 批准号:
10608129 - 财政年份:2021
- 资助金额:
$ 7.15万 - 项目类别:
The role of Absent in Melanoma 2 (Aim2) in CD8+ T cell regulation and Helicobacter-induced gastric pathology
黑色素瘤 2 缺失 (Aim2) 在 CD8 T 细胞调节和螺杆菌诱导的胃病理学中的作用
- 批准号:
10041108 - 财政年份:2020
- 资助金额:
$ 7.15万 - 项目类别:
The role of Absent in Melanoma 2 (Aim2) in CD8+ T cell regulation and Helicobacter-induced gastric pathology
黑色素瘤 2 缺失 (Aim2) 在 CD8 T 细胞调节和螺杆菌诱导的胃病理学中的作用
- 批准号:
10198725 - 财政年份:2020
- 资助金额:
$ 7.15万 - 项目类别: